MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$10,936K
Free Cash flow
$10,217K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Depreciation and amortization ex...
Stock-based compensation expense
Non-cash interest expense
Others
Negative Cash Flow Breakdown
Accounts receivable
Purchases of property, plant and...
Inventory
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
14,682
7,315
105,383
24,319
Depreciation and amortization expense
10,242
11,864
7,468
6,849
Stock-based compensation expense
8,606
9,952
9,395
9,136
Deferred taxes
3,799
1,067
-83,543
-
Non-cash interest expense and end of term accretion expense
-
-
706
796
Non-cash interest expense
4,639
4,593
-
-
Non-cash lease expense
-
-
585
550
Non-cash operating lease expense
619
610
-
-
Unrealized foreign currency transaction (gains) losses
-166
-486
141
8
Loss on disposal of fixed assets
-
-
0
0
Accounts receivable
13,428
6,520
3,582
-24,148
Inventory
6,350
3,896
6,531
6,902
Prepaid expenses and other current assets
4,349
-1,961
-1,060
5,900
Other non-current assets
87
155
13
6
Accounts payable
1,598
1,126
-2,064
2,455
Accrued expenses and other current liabilities
-2,230
-3,105
6,966
13,141
Deferred revenue
185
40
-399
1,735
Operating lease liabilities
-783
-805
-777
-740
Net cash provided by operating activities
17,309
24,533
34,513
69,573
Purchases of property, plant and equipment
7,092
36,657
15,514
7,624
Net cash used in investing activities
-7,092
-36,657
-15,514
-7,624
Proceeds from issuance of common stock upon exercise of stock options
1,009
2,212
3,099
1,816
Proceeds from issuance of common stock in connection with employee stock purchase plan
0
1,688
0
1,963
Tax withholding payments related to net settlement of restricted stock units
39
138
0
138
Net cash provided by financing activities
970
3,762
3,099
3,641
Effect of exchange rate changes on cash and restricted cash
-251
-327
94
9
Net increase in cash and restricted cash
10,936
-8,689
22,192
65,599
Cash and restricted cash, beginning of period
480,177
488,866
466,674
337,150
Cash and restricted cash, end of period
491,113
480,177
488,866
466,674
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income
$14,682K
(-75.77%↓ Y/Y)
Depreciation and
amortization expense
$10,242K
(-20.41%↓ Y/Y)
Proceeds from issuance of
common stock upon...
$1,009K
(-88.57%↓ Y/Y)
Stock-based compensation
expense
$8,606K
(-53.05%↓ Y/Y)
Non-cash interest
expense
$4,639K
Deferred taxes
$3,799K
Accounts payable
$1,598K
(489.76%↑ Y/Y)
Non-cash operating lease
expense
$619K
Deferred revenue
$185K
(196.35%↑ Y/Y)
Unrealized foreign
currency transaction...
-$166K
(-111.27%↓ Y/Y)
Net cash provided by
operating activities
$17,309K
(-80.50%↓ Y/Y)
Net cash provided by
financing activities
$970K
(-90.41%↓ Y/Y)
Canceled cashflow
$27,227K
Canceled cashflow
$39K
Net increase in cash
and restricted cash
$10,936K
(-82.89%↓ Y/Y)
Canceled cashflow
$7,343K
Accounts receivable
$13,428K
(102.96%↑ Y/Y)
Inventory
$6,350K
(211.07%↑ Y/Y)
Prepaid expenses and
other current assets
$4,349K
(502.31%↑ Y/Y)
Accrued expenses and
other current...
-$2,230K
(7.58%↑ Y/Y)
Operating lease
liabilities
-$783K
(43.18%↑ Y/Y)
Other non-current
assets
$87K
(2075.00%↑ Y/Y)
Tax withholding
payments related to net...
$39K
Net cash used in
investing activities
-$7,092K
(80.36%↑ Y/Y)
Effect of exchange rate
changes on cash and...
-$251K
(-121.51%↓ Y/Y)
Purchases of property,
plant and equipment
$7,092K
(-80.36%↓ Y/Y)
Buy us a coffee
TransMedics Group, Inc. (TMDX)
TransMedics Group, Inc. (TMDX)